Pfizer, Inc. News

Do you have an interest in the products developed by Pfizer, Inc., or are you interested in the performance of the company? If you are you should register for the free Pfizer, Inc. news email from Wiser. Pfizer, Inc. is an American-based pharmaceutical company that researches, develops and manufactures medicines and vaccines. The products developed by the company are used all over the world. They include leading brands like Lipitor, Zithromax and Viagra. The company was founded in 1849 and today is one of the largest pharmaceutical companies in the world. Its current chairman and CEO is Ian Reed. Most analysts expect Pfizer, Inc. to expand through acquisitions over the coming years. The Wiser daily Pfizer, Inc. news email covers this news as well as analysis on the performance of the company, and details about its products. These articles come from the best sources around the web and are delivered in a comprehensive but simple to use format. Sign up today.

Recent Pfizer, Inc. News Coverage
 
Your Weekly Recommendations Wednesday, April 25, 2018
 
Recommended for you
David Crosby Is 'Home Free' in New Music Video: Exclusive Premiere
Billboard Biz • Paul Bond
Senator calls out drugmakers for buying back stocks rather than slashing prices for consumers
Becker's Hospital Review • Kelly Gooch
The Health 202: Food stamp work requirements won't work if states don't do their part
Washington Post • Paige Winfield Cunningham
First Edition: April 13, 2018
Kaiser Health News
Epipen and EpiPen Jr. in short supply, Health Canada warns
CBC Radio-Canada • Cbc News
Bad Investments
Seeking Alpha • Derek Lowe
Corrections: April 12, 2018
The New York Times
Generics Companies Who Make Bread-And-Butter Pills Instead Of Fancy Blockbusters Face A Crisis
Kaiser Health News
Pfizer's Inlyta flunks late-stage label-expansion study
Seeking Alpha • Douglas W. House
With Alzheimer’s Failure, vTv Fares No Better Than Old Partner Pfizer
Xconomy • Frank Vinluan
 
Recommended for You
Music Industry, Pfizer, Inc.
David Crosby Is 'Home Free' in New Music Video: Exclusive Premiere
Billboard BizPaul Bond
The song is featured in the film "Little Pink House," which comes out April 20. Before legendary rocker David Crosby releases his newest music video -- which serves as a cross-promotion of an upcoming movie he is backing -- Billboard has obtained...
Share
Finance, Investment Industry
Senator calls out drugmakers for buying back stocks rather than slashing prices for consumers
Becker's Hospital ReviewKelly Gooch
An analysis by Sen. Cory Booker, D-N.J., suggests the nation's largest pharmaceutical companies do not plan to use new tax savings to lower prescription drug prices for consumers. For the 15-page analysis, Mr. Booker's office examined transcripts of the fourth-quarter 2017 earnings...
Share
Elections & Polls, Epidemiology
The Health 202: Food stamp work requirements won't work if states don't do their part
Washington PostPaige Winfield Cunningham
You are reading The Health 202, our must-read newsletter on health policy. Not a regular subscriber? SIGN UP NOW AGENCY ALERT Substance Abuse and Mental Health Administration will receive an additional $1 billion to support additional treatment, prevention, and recovery services National...
Share
Health Care Industry, Health Care Provision
First Edition: April 13, 2018
Kaiser Health News
Today's early morning highlights from the major news organizations.
Share
Health Care Industry, Health Care Provision
Epipen and EpiPen Jr. in short supply, Health Canada warns
CBC Radio-CanadaCbc News
Pfizer said the current EpiPen supply constraints are due to manufacturing delays. (Rich Pedroncelli/Associated Press) EpiPen injectors used to treat life-threatening allergic reactions are currently running short, and EpiPen Jr. products may soon do the same, Health Canada said on Thursday. Health...
Share
Health Finance, Pfizer, Inc.
Bad Investments
Seeking AlphaDerek Lowe
Here are some sequels to stories I've written about here, things that have had some new chapters added to them. First off, this 2015 post mentions the steep drop in shares of Clovis Biotechnology (NASDAQ:CLVS), brought on by a rather sudden revision...
Share
Google Inc, News Media
Corrections: April 12, 2018
The New York Times
BUSINESS DAY An article on Saturday about medical devices made in China that a Trump administration proposal is targeting for a potential 25 percent tariff erroneously included Pfizer among a group of manufacturers that declined to comment on the proposal. Pfizer was...
Share
Health Insurance, Health Reform
Generics Companies Who Make Bread-And-Butter Pills Instead Of Fancy Blockbusters Face A Crisis
Kaiser Health News
News outlets report on stories related to pharmaceutical pricing.
Share
Cancer, Pfizer, Inc.
Pfizer's Inlyta flunks late-stage label-expansion study
Seeking AlphaDouglas W. House
The independent Data Monitoring Committee (DMC) has recommended the termination of a Phase 3 clinical trial, ATLAS, evaluating Pfizer's (PFE +1.5%) INLYTA (axitinib) as adjuvant therapy for patients at high risk of recurrent renal cell carcinoma (RCC) after the removal of a...
Share
Pfizer, Inc., Pharmaceuticals
With Alzheimer’s Failure, vTv Fares No Better Than Old Partner Pfizer
XconomyFrank Vinluan
Raleigh-Durham — When vTv Therapeutics reacquired its ineffective Alzheimer’s drug from Pfizer in 2011, it thought it could produce better results by testing it in a larger group of patients. On Monday, vTv’s gambit proved unsuccessful. Like so many other Alzheimer’s drugs...
Share